Skip to main content
RGNT logo

RGNT

Regentis Biomaterials Ltd.
$3.93 -0.10 (-2.48%) At close · Jul 6
Market Cap
$20.35M
Shares
5,179,378

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 3
Total Value: $1,685,882
Total Shares: 551,844

Institutional Ownership Trend

2 quarters

Holder Concentration

Across 3 13F filers · Δ vs Dec 31, 2025
Top Holder
54.4%
Dec 2025 → Mar 2026 · range 54.4% – 89.5%
−35.1 pts
Top 5
100.0%
Dec 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
Top 10
100.0%
Dec 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
5,033
Dec 2025 → Mar 2026 · range 5,033 – 8,070
Highly concentrated−3,038

Quarterly Activity

vs Dec 31, 2025
New
2
Increased
0
Decreased
0
Sold Out
3
Unchanged
1
Holder count: -1
Institutional value: -84.5%
Shares held: -65.8%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 3 of 3
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1912966 CUSIP M8211G108 Visit website Investor relations